Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography

Fig. 3

Left: ctO2Hb changes after 2–3 weeks of chemotherapy showing a significant decrease for pCR patients but a non-significant change for the non-pCR group. Right: Box plot of the difference between ctO2Hb levels measured at baseline and after 2–3 weeks under Taxane regimen (TP1) for pCR and non-pCR patients showing a significant difference between both groups. ctO2Hb reduction levels at TP1 were larger for pCR patients

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us